Alexandria Venture Investments was among the investors in a series C round for Codiak Biosciences, based on research at Gothenburg and Texas universities.

Codiak BioSciences, a US-based exosome therapeutics company, closed a $76.5m series C round yesterday backed by Alexandria Venture Investments, the investment arm of life science real estate developer Alexandria Real Estate Equities.

Qatar Investment Authority, the sovereign wealth fund of Qatar and Alaska Permanent Fund, owned by the US state of Alaska, also contributed, as did Arch Venture Partners, Flagship Pioneering, Fidelity Management and Research Company, Boxer Capital, Sirona Capital, EcoR1 Capital and Casdin Capital.

Codiak Biosciences is working on…